- Why Toronto
- Startup Support
- Events & Training
- About Us
Get Social with Us
Associate Professor James Carlyle was unconvinced at first. His doctoral student Oscar Aguilar had just brought him lab data showing how “natural killer” or NK cells, a key part of the immune system’s defence against pathogens and cancer, are targeted by a common virus.
Toronto’s under-tapped market offers investors cutting-edge biotech and life sciences startups
On the 7th floor of Toronto’s St. Michael‘s Hospital is a small space with big, innovative ideas. It’s the office of the Biomedical Zone (BMZ), a startup incubator led by physicians in a clinical environment. There, startups work with clinicians one-on-one to develop tech within the settings in which they will be used.
Andrew Fraser and Peter Roy lead research into identifying new drugs that can fight parasites infecting the gut, lungs and livers of two billion people globally – many of whom live in poor and marginalized communities.
MaRS is hostings its second RESI Conference, which will bring together fundraising CEOs and early-stage investors from around the globe in Toronto on April 4.